Bajaj Healthcare Ltd Grants Stock Options Under Employee Stock Option Plan 2024
Bajaj Healthcare Limited has approved the grant of stock options to eligible employees under the Bajaj Healthcare Limited Employee Stock Option Plan 2024. The Nomination and Remuneration Committee sanctioned the grant, setting a fixed exercise price for the new options.The company granted a total of 275 stock options to qualified employees as part of the plan. Each option was set at an exercise price of Rs 5/-. These options are covered by the plan which mandates that each ESOP can be converted into one fully paid up equity share, valued at Rs 5/-.
Key operational details regarding the Employee Stock Option Plan 2024 include:
| Particulars | Details |
|---|---|
| Total Options Granted | 275 options |
| Exercise Price per ESOP | Rs 5/- |
| Vested Options Available | 2,500 options |
| Vesting Period Constraint | Maximum of 4 years from the date of grant |
| Minimum Grant to Vesting Period | One year |
The scheme’s eligibility criteria stipulate that participants must be an employee working in India or outside India, a Director who holds over 10% of the issued and subscribed Shares, or an Independent Director. The plan excludes any Promoter or employees belonging to the Promoter Group.
Regarding implementation terms, all vested options may be exercised by the Option Grantee within a period of five years from the date of vesting for respective options. A critical term noted in the plan is that the shares arising from the exercise of Vested Options will not be subject to any lock-in period.
BAJAJHCARE Stock Price Movement
Bajaj Healthcare Limited rallied today, posting a solid gain of 4.56% and settling at ₹386.55 after market close. The stock traded over one million shares throughout the day, successfully navigating an intraday range between ₹375.1 and ₹394.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.